
Truveta
Saving lives with data by providing regulatory-grade safety and effectiveness data.

Advanced AI-Driven Mammography Solutions for Early Breast Cancer Detection and Workflow Optimization

CureMetrix stands at the forefront of the 2026 medical imaging market, providing FDA-cleared AI software that transforms the standard of care in mammography. Their technical architecture is built upon the proprietary Quantifi™ algorithm, designed to assist radiologists in identifying and quantifying suspicious lesions with high sensitivity and low false-positive rates. Unlike traditional CAD (Computer-Aided Detection), CureMetrix utilizes advanced deep learning to prioritize clinical worklists via cmTriage, ensuring that suspicious cases are flagged for immediate review. By 2026, the platform has matured into a comprehensive breast health ecosystem, integrating cmAssist for lesion detection and cmScore for objective density and risk assessment. The solution is typically deployed as a cloud-based or hybrid-cloud service, integrating seamlessly into existing DICOM and HL7 workflows. Its market position is defined by its ability to reduce radiologist burnout while simultaneously improving clinical outcomes through earlier detection of calcifications and masses, particularly in dense breast tissue where traditional methods often fail.
CureMetrix stands at the forefront of the 2026 medical imaging market, providing FDA-cleared AI software that transforms the standard of care in mammography.
Explore all tools that specialize in breast density assessment. This domain focus ensures CureMetrix delivers optimized results for this specific requirement.
Algorithms analyze the entire patient worklist to flag suspicious cases for prioritized reading by the radiologist.
AI-CAD tool that detects and marks potential masses and calcifications with a focus on false-positive reduction.
Provides a proprietary numerical score (0-100) representing the algorithm's confidence in a finding.
Automatically standardizes metadata from disparate imaging hardware (GE, Hologic, Siemens).
Automated breast density assessment for categorized risk stratification.
AI findings are injected directly into existing PACS viewers via DICOM overlays.
Deep learning models that compare current scans to historical data to detect subtle changes.
Clinical and Technical Needs Assessment with CureMetrix solutions architects.
Provisioning of secure site-to-site VPN or TLS-encrypted cloud tunnel.
Configuration of the CureMetrix Edge appliance or Cloud Gateway.
Integration with DICOM modality worklists or PACS image routing.
Mapping of HL7 metadata for patient synchronization.
Configuration of cmTriage worklist priorities within the local RIS/PACS.
User acceptance testing (UAT) with lead radiologists.
Clinical staff training on AI overlay interpretation and scoring.
Security and HIPAA compliance final audit.
Production Go-Live and continuous performance monitoring.
All Set
Ready to go
Verified feedback from other users.
"Highly regarded for clinical accuracy and seamless workflow integration. Users report significant reduction in false positives compared to legacy CAD solutions."
Post questions, share tips, and help other users.

Saving lives with data by providing regulatory-grade safety and effectiveness data.

Breast AI trusted for better workflow and higher confidence in mammography screening.

Assistive communication solutions for people with disabilities.

Turn your diabetes data points into accessible, actionable, and meaningful insights.

Science-backed supplements for personalized wellness.

Hear everything in a heartbeat with advanced digital stethoscope technology.